These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37861525)

  • 1. Identification of pyroptosis-related lncRNA subtype and signature predicts the prognosis in bladder cancer.
    Zeng T; Ye J; Wang H; Tian W
    Medicine (Baltimore); 2023 Oct; 102(42):e35195. PubMed ID: 37861525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pyroptosis-related lncRNA signature in bladder cancer.
    Wang P; Wang Z; Zhu L; Sun Y; Castellano L; Stebbing J; Yu Z; Peng L
    Cancer Med; 2023 Mar; 12(5):6348-6364. PubMed ID: 36237132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis Risk Model Based on Pyroptosis-Related lncRNAs for Bladder Cancer.
    Lu Z; Tang F; Li Z; Lai Y; Lu Z; Zhang J; Tang Z; Cai W; He Z
    Dis Markers; 2022; 2022():7931393. PubMed ID: 35154513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer.
    Lu H; Wu J; Liang L; Wang X; Cai H
    Front Immunol; 2022; 13():803355. PubMed ID: 35154117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Zhu W; Ye Z; Chen L; Liang H; Cai Q
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a pyroptosis-associated long non-coding RNA signature for predicting the immune status and prognosis in skin cutaneous melanoma.
    Wu L; Liu G; He YW; Chen R; Wu ZY
    Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5597-5609. PubMed ID: 34604952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel cuproptosis-related lncRNA signature predicts the prognosis and immune landscape in bladder cancer.
    Bai Y; Zhang Q; Liu F; Quan J
    Front Immunol; 2022; 13():1027449. PubMed ID: 36451815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancer.
    Ma T; Wang X; Meng L; Liu X; Wang J; Zhang W; Tian Z; Zhang Y
    BMC Cancer; 2021 Nov; 21(1):1256. PubMed ID: 34802433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a Novel Pyroptosis-Associated lncRNA Biomarker Signature in Lung Adenocarcinoma.
    Wang P; Wang Z; Lin Y; Castellano L; Stebbing J; Zhu L; Peng L
    Mol Biotechnol; 2024 Feb; 66(2):332-353. PubMed ID: 37154865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and validation of the pyroptosis-related long noncoding rna signature to predict the prognosis of patients with bladder cancer.
    Wu Z; Zeng J; Wu M; Liang Q; Li B; Hou G; Lin Z; Xu W
    Medicine (Baltimore); 2023 Feb; 102(8):e33075. PubMed ID: 36827075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide Exploration of a Pyroptosis-Related Long Non-Coding RNA Signature Associated With the Prognosis and Immune Response in Patients With Bladder Cancer.
    Gao X; Cai J
    Front Genet; 2022; 13():865204. PubMed ID: 35571063
    [No Abstract]   [Full Text] [Related]  

  • 12. m6A-immune-related lncRNA prognostic signature for predicting immune landscape and prognosis of bladder cancer.
    Feng ZH; Liang YP; Cen JJ; Yao HH; Lin HS; Li JY; Liang H; Wang Z; Deng Q; Cao JZ; Huang Y; Wei JH; Luo JH; Chen W; Chen ZH
    J Transl Med; 2022 Oct; 20(1):492. PubMed ID: 36309694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration.
    Wang Z; Cao L; Zhou S; Lyu J; Gao Y; Yang R
    Front Immunol; 2022; 13():854785. PubMed ID: 35392086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of pyroptosis-related lncRNAs prediction model for bladder cancer.
    Lia T; Shao Y; Regmi P; Li X
    Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 35024796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An innovative pyroptosis-related long-noncoding-RNA signature predicts the prognosis of gastric cancer
    Xiong S; Jin L; Zeng C; Ma H; Xie L; Liu S
    Pathol Oncol Res; 2022; 28():1610712. PubMed ID: 36567977
    [No Abstract]   [Full Text] [Related]  

  • 16. A five necroptosis-related lncRNA signature predicts the prognosis of bladder cancer and identifies hot or cold tumors.
    Li H; Lv Z; Liu M
    Medicine (Baltimore); 2023 Oct; 102(41):e35196. PubMed ID: 37832111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer.
    Wang L; Xiao K; Dong Z; Meng T; Cheng X; Xu Y
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10543-10559. PubMed ID: 37291405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of prognostic risk model of bladder cancer based on cuproptosis-related long non-coding RNAs.
    Xu C; Chen A; Mao C; Cui B
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 52(2):139-147. PubMed ID: 37283097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and verification of an immune-related lncRNA signature for predicting the prognosis of patients with bladder cancer.
    Wang J; Shen C; Dong D; Zhong X; Wang Y; Yang X
    Int Immunopharmacol; 2021 Jan; 90():107146. PubMed ID: 33189610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and verification of the pyroptosis-related prognostic signature and its associated regulatory axis in bladder cancer.
    Tu Y; Ding X; Mao Z
    Front Cell Dev Biol; 2022; 10():912008. PubMed ID: 36120583
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.